12:00 AM
 | 
Feb 25, 2013
 |  BC Week In Review  |  Company News  |  Deals

Cepheid, Oregon Health & Science University deal

Cepheid partnered with the university's Knight Cancer Institute to develop molecular cancer diagnostics for Cepheid's GeneXpert System. The deal will initially focus on breast and prostate cancer tests including the Xpert Breast Cancer Signature, which...

Read the full 153 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >